Q2 EARNINGS: Wright falls short of analyst expectations, Integra boosted by neuro offering
This article was originally published in Clinica
Executive Summary
Orthopedic firm Wright Medical fell short of analyst expectations during Q2. Although sales grew 19% year-on-year to $72.4m, this was still $1.77m less than predicted. In addition, an adjusted net loss of $0.48 per diluted share was $0.03 worse than expected. The firm’s share price was down 3% at $30.21 as Clinica went to press on 6 August, the day after it reported the results.